Brian C. Stephenson, CFO and Treasurer at BridgeBio Pharma, Inc. (BBIO), sold 8,500 shares at $33.18 ($282K) on 2025-02-25, disclosed to the SEC on 2025-02-27.
Scheduled sale ($282k) by CFO and Treasurer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.18 | 8,400 | $279K | 98.8% |
| 2 | $34.18 | 100 | $3K | 1.2% |
| Total | $33.19 avg | 8,500 | $282K | 100% |
| Filing → |
| FTH | BUY | 2026-06-24 | $406K | — | Filing → |
| BBIO | SELL | 2025-02-19 | $300K | — | Filing → |
| BBIO | SELL | 2025-01-30 | $2.5M | — | Filing → |